Before installing or using an X-ray source in the workplace, employers must register with the Radiation Protection Service (RPS). To register, you must submit an application form along with the floor plan drawings indicating where the X-ray source will be located. RPS will review the submission and, once you have received confirmation of approval, you can install and use the X-ray source in the workplace.
This forms part of the expedited process for existing municipal and non-municipal drinking water systems applying for regulatory relief in accordance with s. 38 and s.60 of the Safe Drinking Water Act (SDWA), from strict sampling requirements for lead and other parameters under Schedule 15.1 of Regulation 170/03 (Drinking Water Systems).
The use of this aid is voluntary. It is being provided to assist you in maintaining records for medical assistance in dying. Please use this aid if you are a “Medical Practitioner” or “Nurse Practitioner” and a patient is requesting a Waiver of Final Consent. The Waiver of Final Consent is ONLY applicable for individuals whose natural death is reasonably foreseeable (RFND).
This guide is intended to support intermediaries to access and use the OBR Partner Portal on behalf of their respective business clients. In general, it provides information about accessing the Partner Portal, adding users, claiming authority of business profiles, and navigating its functions. This guide is not intended for fee-exempt users of the portal.
Form used to register waste generation activity. Use of this form is only permitted if the Director has approved a request to satisfy submission requirements by using a paper document.
This form is only to be used by prescribers to request an exemption for Ontario’s Biosimilar Switch Policy for a patient who HAS BEEN USING AN ORIGINATOR BIOLOGIC REIMBURSED THROUGH THE ONTARIO DRUG BENEFIT (ODB) PROGRAM previously authorized through the Exceptional Access Program and is unable to switch from an originator biologic or who is requesting to switch back to the originator following biosimilar switch.
